Intensity Therapeutics, Inc. Provides Update On The Phase 2 Presurgical Triple-Negative Breast Cancer INVINCIBLE-4 Study | News | Slzii.com

Slzii.com Search

Search (News)

All countries United states (us) Great Britain (gb) Netherlands (nl) Finland (fi) Australia (au) Singapore (sg) Germany (de) Mexico (mx) Norway (no) Austria (at) Spain (es) Denmark (dk) Sweden (se) Canada (ca) Taiwan (tw) France (fr) South Korea (kr) Chile (cl) Italy (it) China (cn) Portugal (pt) Switzerland (ch) Brazil (br) Serbia (rs) Japan (jp) Bulgaria (bg) South Africa (za) Slovenia (si) Poland (pl) Romania (ro) Philippines (ph) Latvia (lv) Bosnia and Herzegovina (ba) hans New Zealand (nz) hant Thailand (th) Greece (gr) India (in) Iran (ir) United Arab Emirates (ae) Czech Republic (cz) Belgium (be) Turkey (tr) Georgia (ge) Argentina (ar) Slovakia (sk) Indonesia (id) Hungary (hu) Laos (la) latn Russia (ru) Ireland (ie) Hong Kong (hk) 1996 ms Andorra (ad) Estonia (ee) Pakistan (pk) Ukraine (ua) Vietnam (vn) Lithuania (lt) cmn en Colombia (co) Greenland (gl) Peru (pe) North Macedonia (mk) Malta (mt) Albania (al) Israel (il) Malaysia (my) Kazakhstan (kz) cyrl glob inter Azerbaijan (az) Tunisia (tn) Moldova (md) uk Saudi Arabia (sa) location Ivory Coast (ci) Ecuador (ec) aa Algeria (dz) us” el simple oc zh Curaçao (cw) Egypt (eg) emea lang corporate landing Aruba (aw) eu Morocco (ma) Croatia (hr) Kenya (ke) 150 Zimbabwe (zw) Tajikistan (tj) 8 informal Venezuela (ve) int Belarus (by) Sierra Leone (sl) 419 Zambia (zm) default Uruguay (uy) Luxembourg (lu) Rwanda (rw) Paraguay (py) Trinidad and Tobago (tt) de.utf8 Nigeria (ng) Ghana (gh) El Salvador (sv) 001 Uzbekistan (uz) Angola (ao) wo Bangladesh (bd) berne Guatemala (gt) Puerto Rico (pr) cs bal Montenegro (me) Qatar (qa) Cyprus (cy) cn;zh Armenia (am) langkey} Dominican Republic (do) Kuwait (kw) language Iceland (is) Honduras (hn) xx Panama (pa) Bolivia (bo) Tanzania (tz) Costa Rica (cr) us" Ethiopia (et) Syria (sy) Senegal (sn) Afghanistan (af) zz Mauritius (mu) code} cn" global Gambia (gm) formal pl" new Lebanon (lb) br, pt Namibia (na) Oman (om) vx Lesotho (ls) us.utf Kyrgyzstan (kg) fi2 x ap cht enloyd br, en Sudan (sd) static fo Jordan (jo) yu Belize (bz) mts nl" Uganda (ug) Bahrain (bh) zn Myanmar (mm) Suriname (sr) Republic of the Congo (cg) Nepal (np) gb.utf8 hans" Somalia (so) chs Madagascar (mg) ko Jamaica (jm) com United States Virgin Islands (vi) Swaziland (sz)

Language

All languages German (de) English (en) Dutch (nl) French (fr) Finnish (fi) Japanese (ja) Estonian (et) Spanish (es) Norwegian (no) Danish (da) Swedish (sv) Portuguese (pt) Russian (ru) nb Chinese (Simplified) (zh) Korean (ko) Italian (it) Serbian (sr) Czech (cs) Bulgarian (bg) Thai (th) Polish (pl) Slovene (sl) Lithuanian (lt) Croatian (hr) Ukrainian (uk) Hungarian (hu) Romanian (ro) Greek (el) Latvian (lv) Bosnian (bs) Indonesian (id) Vietnamese (vi) Hebrew (he) Persian (fa) se Slovak (sk) Arabic (ar) Basque (eu) nn Catalan (ca) eng Turkish (tr) Georgian (ka) Azerbaijani (az) Macedonian (mk) jp Kazakh (kk) Belarusian (be) Sinhalese (si) GR ge gr gl gb cmn kz cn Kinyarwanda (rw) Albanian (sq) Tajik (tg) Kanuri (kr) tj Icelandic (is) cnr ch Odia (or) Hindi (hi) Maltese (mt) Malayalam (ml) choose Breton (br) Amharic (am) Uzbek (uz) Telugu (te) ”en us tc Assamese (as) gf fre Irish (ga) pap fil me Urdu (ur) ua cz lu Hausa (ha) Malay (ms) gu Cymraeg (cy) zn nd Swahili (sw) fo Bengali (bn) sh utf Somali (so) Khmer (km) x oz ma knx mx Chinese (Traditional) (tw) fl Ewe (ee) gsw vn Tigrinya (ti) en,zh sd Kannada (kn) Mongolian (mn) glo rm dk af Armenian (hy) old ba rs "en ie Tamil (ta) sa Pashto (ps) ed wo Tagalog (Filipino) (tl) Marathi (mr) by co au Burmese (my) sg Lao (lo) Haitian Creole (ht) "pl Kyrgyz (ky) wprentals za Yoruba (yo) Punjabi (pa) at oc Sesotho (st) in hk com AL ae undefined ru> Frisian (fy) kg "nl xx om Kurdish (ku) al Nepali (ne) "zh s1 ip eo

Intensity Therapeutics, Inc. Provides Update On The Phase 2 Presurgical Triple-Negative Breast Cancer INVINCIBLE-4 Study
(MENAFN - PR Newswire) Preliminary observations of the INVINCIBLE-4 Study to date showed that five (5) out of seven (7) patients (71.4%) who received INT230-6 prior to standard of care ("SOC") ...
2026-03-12 07:47:53

Search (News)

What are you doing?